Disabled-1 (Dab1) is best known as an adaptor protein regulating neuron migration and lamination during development. However, the exact function of Dab1 in breast cancer is unknown. In this study, we examined the expression of Dab1 in 38 breast cancer paraffin sections, as well as 60 paired frozen breast cancer and their adjacent tissues. Our results showed that Dab1 was reduced in breast cancer, and its compromised expression correlated with triple negative breast cancer phenotype, poor differentiation, as well as lymph node metastasis. Functional analysis in breast cancer cell lines demonstrated that Dab1 promoted cell apoptosis, which, at least partially, depended on its regulation of NF-κB/Bcl-2/caspase-9 pathway. Our study strongly suggests that Dab1 may be a potential tumour suppressor gene in breast cancer.
| INTRODUCTION
Breast cancer, based on the cancer statistics of 2017, is still the most common cancer which accounts for 30% of all new cancer diagnoses. 1 Clinically, tumour stage, histological grade and the status of lymph node have been used as indicators of breast cancer progression, treatment response and prognosis. 2 However, it is still the second most mortality cancer, accounting for 14% of all cancercaused deaths in women. 1 Therefore, identification of novel tumour therapeutic targets is still important for early detection and followup treatments.
Dab1 gene encodes a 555 amino acids protein with an N-terminal PTB domain, a region containing important Tyr residues, and a C-terminal region. 3 It is a well-documented intracellular messenger of reelin signalling pathway, and extremely important for neuron migration and lamination in developing brain. 4 Common fragile sites (CFS) are large chromosomal regions of instability existing in all individuals, and proteins coded by genes with CFS are usually demonstrated to be tumour suppressors. 5 A study reported that Dab1 gene was a lines or primary tumours of ovary, prostate, breast, endometrium and brain. 6 However, the role of 
| MATERIALS AND METHODS
Antibodies and reagents, as well as experimental details, were described in Supplementary Materials and Methods. (Table S1 ). The 60 frozen specimens, used for protein and mRNA extraction, were collected from patients receiving surgery with non-preoperative therapy between January 2017 and July 2017 (Table S2) Univariate and multivariate analysis using binary logistic regression (backward) were performed to characterize the association between breast cancer aggressiveness and clinicopathologic factors, and lymph node metastasis (Table S3, NF-κB is a transcription factor involved in cell apoptosis, and its increased transcription resulted in reduced apoptosis. The p65/p50
heterodimer is particularly relevant in regulating the expression of apoptotic proteins, such as anti-apoptotic protein Bcl2. 14 Here, we found NF-κB p65 ser536 phosphorylation, a well-known active marker for NF-κB, 15 Dab1 has been reported to be strongly down-regulated in glioblastoma 17 and neuroblastoma. 18 In breast cancer, McAvoy has firstly reported the down-regulation of Dab1, and overexpression of Dab1 resulted in decreased cell survival. 6 Here, according to our study, the inhibited cell survival caused by Dab1 was resulted from For all statistics analysis in this figure, *P < 0.05; ***P < 0.001
